Oliver Pérez-Bautista

Oliver Pérez-Bautista


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2019 in Biomolecules
Verified
Journal Article
Open access
PDF file
YVYadira Velasco-Torres
Yadira Velasco-Torres
VRVictor Ruiz
Victor Ruiz
MMMartha Montaño
Martha Montaño
RPRogelio Pérez-Padilla
Rogelio Pérez-Padilla
Ramcés Falfán-ValenciaRamcés Falfán-Valencia
Ramcés Falfán-Valencia
CRCarlos Ramos
Carlos Ramos
Chronic obstructive pulmonary disease (COPD) is characterized by airflow limitation and systemic inflammation. The main causes of COPD include interaction between genetic and environmental factors associated with tobacco smoking (COPD-TS) and/or exposure to biomass smoke (COPD-BS). Several microRNAs (miRNAs) control posttranscriptional regulation of COPD-TS associated gene expression. The miR-22-HDAC4-IL-17 axis was recently characterized. It is still unknown, however, whether this axis, participates in COPD-BS. To investigate, 50 patients diagnosed with severe-to-very severe COPD GOLD (Global Initiative for Chronic Obstructive Lung Disease) stages III/IV, were recruited, 25 women had COPD-BS (never smokers, exposed heavily to BS) and 25 had COPD-TS. Serum levels of miRNA-22-3p were measured by RT (Reverse Transcription)-qPCR, while the concentration of HDAC4 (Histone deacetylase 4) was detected by ELISA. Additionally, we looked for association between serum HDAC4 and DLCOsb (Single-breath diffusing capacity of the lung for carbon monoxide), as % of predicted by age, height, and gender, one of the main differences described between COPD-BS and COPD-TS. Women with COPD-BS were older and shorter and had a higher DLCOsb %P (percent predicted) compared to COPD-TS. Serum miR-22-3p was downregulated in COPD-BS relative to COPD-TS. In contrast, the concentration of HDAC4 was higher in COPD-BS compared to COPD-TS. Furthermore, a positive correlation between serum HDAC4 levels and DLCOsb %P was observed. We concluded that the miR-22-HDAC4-DLCO axis behaves differently in patients with COPD-BS and COPD-TS.

4 December 2018 in Respiratory Research
Verified
Journal Article
Open access
PDF file
OPOliver Pérez-Bautista
Oliver Pérez-Bautista
MMMartha Montaño
Martha Montaño
RPRogelio Pérez-Padilla
Rogelio Pérez-Padilla
JZJoaquín Zúñiga
Joaquín Zúñiga
MCMariana Camacho-Priego
Mariana Camacho-Priego
CRCarlos Ramos
Carlos Ramos
The main causes of COPD are tobacco smoking (COPD-TS) and biomass smoke exposure (COPD-BS). COPD-TS is known to induce changes in adipokines, incretins, and peptide hormones, frequent biomarkers of inflammation; however, it is unknown if similar changes occur in COPD-BS. Clinical and physiological characteristics, and serum concentration of C-peptide, ghrelin, GIP, GLP-1, glucagon, insulin, leptin, PAI-1, resistin, and visfatin were measured in women with COPD-BS, COPD-TS, and healthy controls. Data were compared with one-way ANOVA and Tukey’s post hoc test; nonparametric were expressed as median (interquartile ranges), with Kruskal-Wallis and Dunn’s post-hoc test. Multivariate analysis, age, BMI, MS, and FEV1% pred with levels of inflammatory mediators in COPD women. FEV1% pred, FVC% pred, and FEV1/FVC ratio were decremented in COPD. In COPD-TS increased C-peptide, ghrelin, GIP, GLP-1, and leptin, and reduced glucagon, PAI-1, resistin, and visfatin. In COPD-BS enlarged ghrelin, insulin, leptin, and PAI-1 comparatively with COPD-TS and control, while C-peptide and GLP-1 relatively with controls; conversely, glucagon, and resistin were reduced. Multivariate analysis showed association of ghrelin, insulin, PAI-1, and visfatin with BS exposure. women with COPD-BS have a distinct profile of adipokines, incretins, and peptide hormones, and specifically with ghrelin, insulin, PAI-1, and visfatin related to BS exposure.

5 December 2022 in Age and Ageing
Verified
Journal Article
Open access
PDF file
DPDaniela Patiño-Hernández
Daniela Patiño-Hernández
OPOliver Pérez-Bautista
Oliver Pérez-Bautista
MPMario Ulises Pérez-Zepeda
Mario Ulises Pérez-Zepeda
CCCarlos Cano-Gutiérrez
Carlos Cano-Gutiérrez
Despite the well-known adverse health effects of smoking, evidence of these effects on frail individuals is still scarce. to assess whether frailty influences the association between smoking and mortality. individuals ≥50 years from the Mexican Health and Aging Study were analysed. Mortality rates from a 17-year follow-up were compared between smoking status groups (never, previous and current) and other smoking behaviour-related characteristics (pack-years, age commenced and cessation). Baseline variables were included to adjust the Cox regression models. First, models were adjusted for the whole sample, including an interaction term between the frailty index (FI) and smoking variables. A second set of models were stratified by FI levels: 0.00–0.10, 0.11–0.20, 0.21–0.30 and ≥ 0.31. from a total 14,025 individuals, mean age was 62.4 (95% confidence interval [95% CI]: 62.1–62.8) and 53.9% were women (95% CI: 52.4–55.6). Main results from the survival analyses showed that when including FI interaction term with smoking status, comparing current to never smoking, the hazard ratio (HR) was 2.03 (95% CI: 1.07–3.85, P = 0.029), and comparing current to previous smoking, the HR was 2.13 (95% CI: 1.06–4.26, P = 0.032). Models stratified by FI levels showed a significant HR only for the two highest level groups. Similar results were found for the smoking behaviour-related characteristics. our results suggest that frailty could modify smoking mortality risk. Other smoking characteristics were impacted by frailty, in particular, cessation. It was noteworthy that having ≥10 years of tobacco cessation was beneficial for frail individuals. smoking has a higher toll on frail individuals, but ceasing is still beneficial for this group.

1 September 2025 in IJTLD OPEN
Verified
Journal Article
Open access
RRR. Robles-Hernández
R. Robles-Hernández
RPR. Pérez-Padilla
R. Pérez-Padilla
ARA. Ramírez-Venegas
A. Ramírez-Venegas
YVY. Velasco-Torres
Y. Velasco-Torres
MMM. Montaño
M. Montaño
OPOliver Pérez-Bautista
Oliver Pérez-Bautista
SUMMARY: BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory disease characterised by progressive airflow obstruction. Tobacco smoking is the leading cause of COPD (COPD-TS); however, chronic exposure to biomass smoke (COPD-BS) is the second risk factor. COPD-TS and COPD-BS are now considered different phenotypes, with COPD-BS having small airway dysfunction (SAD). OBJECTIVES: Our primary aim was to investigate the correlation between SAD and the serum levels of interleukins implicated in the maturation and recruitment of eosinophils in women with COPD-BS and COPD-TS. METHODS: This cross-sectional study included 25 women with COPD-BS and 25 women with COPD-TS, and the relationship with SAD was assessed by impulse oscillometry (IOS), alongside measurements of interleukins (IL-1ra, IL-2, IL-4, IL-8, IL-9, IL-13, and IL-17) and eotaxin using the multiplex test (Bio-Plex), in addition to eosinophils total blood. RESULTS: Blood eosinophil count, cytokines, and eotaxin were higher in COPD-BS relative to COPD-TS. IOS measurements were higher in COPD-BS than in COPD-TS. R5–R20 positively correlated with the concentrations of all measured cytokines noted if COPD groups were analysed separately ( P < 0.01). CONCLUSION: Eosinophil counts and cytokines in COPD-BS positively correlate with small airway resistance as measured by IOS in R5–R20.

30 November 2022 in Preprints.org
Verified
Preprint
Open access
PDF file
OPOliver Pérez-Bautista
Oliver Pérez-Bautista
RPRogelio Pérez-Padilla
Rogelio Pérez-Padilla
ARAlejandra Ramirez
Alejandra Ramirez
YVYadira Velasco-Torres
Yadira Velasco-Torres
MMMartha Montaño
Martha Montaño
CRCarlos Ramos
Carlos Ramos
COPD is a chronic inflammatory disease characterized by progressive airflow obstruction. Tobacco smoking is the main cause of COPD (COPD-TS), but chronic exposure to biomass smoke (COPD-BS), mainly wood smoke, is the second risk factor; both are considered to cause different phenotypes of COPD. COPD-BS is more eosinophilic than COPD-TS. The objective of the present study was to evaluate the serum level of interleukins involved in eosinophil maturation, recruitment, and survival, and their association with small airway obstruction, measuring cytokines by multiplex test (Bio-Plex) and evaluating the central airway resistance with impulse oscillometry (IOS), comparatively in patients with COPD due to biomass and smoking. The results showed that IL-1ra, IL-2, IL-4, IL-8, IL-9, IL-13, IL-17, and eotaxin were increased in COPD-BS related to COPD-TS. Resistance parameters showed that R5, X5, AX (area reactance), and R5-R20 were significantly higher in COPD-BS than in the COPD-TS group (p < 0.05). R20 was not different between the groups. These data suggest that the cytokines involved in the effect of eosinophils on airway inflammation in COPD-BS were increased compared with COPD-TS, which appears to be related to a predominance of peripheral airway obstruction in patients with COPD-BS more than in COPD-TS